natgillin/translations-raw huggingface dataset:
No special caution is required for patients with mild renal impairment. 
Pri bolnikih z blago okvarjenim delovanjem ledvic posebna previdnost ni potrebna.
3 pens of 2.4 mL solution each. 
3 injekcijski peresniki, vsak z 2,4 ml raztopine.
Women of childbearing potential should use effective methods of contraception during use of FORSTEO. 
Ženske, ki bi lahko zanosile morajo med uporabo zdravila FORSTEO uporabljati učinkovito metodo kontracepcije.
Injection needles are not included with the pen. 
Igle za injiciranje injekcijskemu peresniku niso priložene.
Studies in rabbits have shown reproductive toxicity (see section 5.3). 
Plodnost Študije na kuncih so pokazale vpliv na sposobnost razmnoževanja (glejte poglavje 5.3).
Pull off needle and throw away as directed by your doctor or pharmacist. 
Odstranite iglo in jo zavrzite v skladu z navodili vašega zdravnika ali farmacevta.
• shortness of breath 
• težko dihanje
NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION FORSTEO 20 micrograms/80 microliters, injection Teriparatide 
IME ZDRAVILA IN POT(I) UPORABE ZDRAVILA FORSTEO 20 mikrogramov/80 mikrolitrov, injekcija teriparatid za subkutano uporabo
Follow the directions carefully when using the pen. 
Pri uporabi injekcijskega peresnika pozorno sledite navodilom.
FORSTEO contains the active substance teriparatide that is used to make the bones stronger, and to reduce the risk of fractures by stimulating bone formation. 
Kaj je zdravilo FORSTEO in za kaj ga uporabljamo Zdravilo FORSTEO vsebuje učinkovino teriparatid, ki jo uporabljamo za krepitev kosti in zmanjšanje tveganja za zlome s spodbujanjem tvorjenja kostnine.
• loss of energy 
• izguba energije • utrujenost
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS LABEL TEXT 
PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH
This user manual was last revised in {MM/YYYY} 
Datum zadnje revizije navodil za uporabo: {MM/YYYY}
Uncommon: may affect up to 1 in 100 people 
Občasni: pojavijo se lahko pri največ 1 od 100 bolnikov:
Hydrochloric acid (for pH adjustment) Sodium hydroxide (for pH adjustment) Water for injections 
6.1 Seznam pomožnih snovi koncentrirana ocetna kislina natrijev acetat (brezvodni) manitol metakrezol klorovodikova kislina (za uravnavanje pH) natrijev hidroksid (za uravnavanje pH) voda za injekcije
Immune System Disorder 
Bolezni imunskega sistema
Transient, orthostatic hypotension or dizziness was observed in some patients. 
Pri nekaterih bolnikih so opažali prehodno ortostatsko hipotenzijo ali omotico.
Teriparatide was not genotoxic in a standard battery of tests. 
V standardnem naboru testov niso ugotovili genotoksičnosti teriparatida.
FORSTEO is indicated in adults. 
4.1 Terapevtske indikacije Zdravilo FORSTEO je indicirano pri odraslih.
Rare: Anaphylaxis 
Pogosto: vrtoglavica
a The incidence of vertebral fractures was assessed in 448 placebo and 444 Forsteo patients who had baseline and follow-up spine radiographs. 
Okrajšave: N = število bolnikov, naključno vključenih v vsako skupino zdravljenja; IZ = interval zaupanja aIncidenca vretenčnih zlomov je bila ocenjena pri 448 bolnikih, ki so prejemali placebo in 444 bolnikih, ki so prejemali zdravilo Forsteo in so imeli radiografijo osnovnega stanja in ponovne ocene hrbtenice.
Respiratory, thoracic and mediastinal disorders Common: Dyspnoea 
Bolezni dihal, prsnega koša in mediastinalnega prostora Pogosto: Dispneja
FORSTEO is a bone formation agent to treat osteoporosis. 
FORSTEO je zdravilo za tvorbo kostnine za zdravljenje osteoporoze.
If you cannot pull out the black injection button see 
Če ne morete potegniti ven črnega gumba za injiciranje glejte Reševanje težav, Problem E.
The pen should be returned to the refrigerator immediately after use. 
Injekcijski peresnik morate takoj po uporabi shraniti nazaj v hladilnik.
1) Put the large needle cover on the needle. 
1) Namestite večji pokrov igle na iglo.
At the 18 month endpoint, FORSTEO significantly increased lumbar spine BMD (7.2 %) compared with alendronate (3.4 %) (p<0.001). 
18 mesecih je zdravilo FORSTEO značilno zvišalo mineralno gostoto kosti (BMD) v ledvenem delu hrbtenice (7,2 %) v primerjavi z alendronatom (3,6 %) (p < 0,01).
4) Pull out the black injection button until it stops. 
4) Potegnite ven črni gumb za injiciranje,
• feeling faint 
• občutek slabotnosti
• Store the FORSTEO with the white cap on. 
• Injekcijski peresnik FORSTEO shranjujte s pritrjenim belim pokrovom.
Yellow Shaft 
Rumeni valj
Uncommon: Injection site erythema, injection site reaction Rare: Possible allergic events soon after injection: acute dyspnoea, oro/facial oedema, generalised urticaria, chest pain, oedema (mainly peripheral). 
Redko: možne alergijske reakcije kmalu po injiciranju: akutna dispneja, edem ust/obraza,
• increase in blood calcium level 
• povišan nivo kalcija v krvi
At 24 months, the mean increase from baseline in lumbar spine, total hip and femoral neck BMD was 10.5 %, 2.6 % and 3.9 % respectively. 
Po 24 mesecih se jim je mineralna gostota kosti (BMD) v ledvenem delu hrbtenice v povprečju povečala za 10,5 %, v celem kolku za 2,6 % in v vratu stegnenice za 3,9 %.
Disposal of Pen Needles and Device Disposal of Pen Needles and FORSTEO Device 
Odstranjevanje igel peresnika in medicinskega pripomočka
Read the user manual booklet, which is included in the carton for instructions on how to use the FORSTEO pen. 
Za navodila, kako uporabiti injekcijski peresnik FORSTEO, preberite Priročnik za uporabo, ki je priložen v škatli.
A. The yellow shaft is still showing after I push in the black injection button. 
A. Po tem ko pritisnem noter črni gumb za injiciranje se še vedno vidi rumeni valj.
Some patients may feel dizzy after injecting FORSTEO. 
Vpliv na sposobnost upravljanja vozil in strojev Nekateri bolniki lahko po injiciranju zdravila FORSTEO čutijo omotico.
Put the pen back into the refrigerator immediately after you have used it. Use a new injection needle for each injection and dispose of it after each use. 
Za vsako injiciranje uporabite novo injekcijsko iglo, ki jo po uporabi zavrzite.
Put large needle cover on needle. 
Namestite večji pokrov igle na iglo.
• Ask your healthcare professional about options to dispose of the pen and the sharps container properly. 
• O pravilnem načinu odstranjevanja peresnika in vsebnika za ostre odpadke se posvetujte z zdravstvenim delavcem.
OTHER Store in a refrigerator 
DRUGI PODATKI Shranjujte v hladilniku.
• breathlessness 
• zadihanost
Non-vertebral fragility fractures c 
Nevretenčni zlomi zaradi krhkostic
Please also refer to the user manual for instructions on how to use the pen. 
Za navodila, kako uporabljati injekcijski peresnik, prosimo, glejte tudi priročnik za uporabo.
Renal impairment Caution should be exercised in patients with moderate renal impairment. 
Okvarjeno delovanje ledvic Pri bolnikih z zmerno okvarjenim delovanjem ledvic je potrebna previdnost.
The pens are available in cartons containing one or three pens. 
Injekcijski peresniki so na voljo v škatlah s po enim ali s tremi injekcijskimi peresniki.
Do not freeze FORSTEO. 
Zdravila FORSTEO ne zamrzujte.
FORSTEO, 20 microgram (µg) 80 microlitres solution for injection, in pre-filled pen 
FORSTEO, 20 mikrogramov (µg) 80 mikrolitrov raztopina za injiciranje v napolnjenem injekcijskem peresniku
Uncommon: Myalgia, arthralgia, back cramp/pain* Renal and urinary disorders 
Občasno: mialgija, artralgija, krč/bolečina v hrbtu* Bolezni sečil
• haemorrhoids (piles) 
• hemoroidi (zlata žila)
• increase in blood uric acid level 
• povišan nivo sečnine v krvi
• increased heart rate 
• porast telesne mase
STATEMENT OF ACTIVE SUBSTANCE(S) Each mL contains 250 micrograms of teriparatide. 
En ml vsebuje 250 mikrogramov teriparatida.
It is supplied in a cartridge contained in a pre-filled disposable pen. 
Na voljo je v vložku v napolnjenem injekcijskem peresniku za enkratno uporabo.
• Refrigerate the FORSTEO immediately after every use. 
• Takoj po vsaki uporabi položite injekcijski peresnik FORSTEO v hladilnik.
FORSTEO is contraindicated for use during breast-feeding. 
Zdravilo FORSTEO je med dojenjem kontraindicirano.
Storing Your FORSTEO 
Shranjevanje vašega injekcijskega peresnika FORSTEO
PEN USER MANUAL 
PRIROČNIK ZA UPORABO
Uncommon: Weight increased, cardiac murmur, alkaline phosphatase increase *Serious cases of back cramp or pain have been reported within minutes of the injection. 
*Nekaj minut po injiciranju so poročali o resnih primerih krča ali bolečine v hrbtu.
After 12 months, BMD had increased in the lumbar spine and total hip by 5 % and 1 %, respectively, compared with placebo. 
Po 12 mesecih se je mineralna gostota kosti (BMD) v ledvenem delu hrbtenice oziroma celem kolku povišala za 5 %
Common: Hypercholesterolaemia 
Presnovne in prehranske motnje Pogosto: hiperholesterolemija
Push in the black injection button until it stops. 
Pritisnite noter črni gumb za injiciranje,
PHARMACEUTICAL FORM Solution for injection. 
FARMACEVTSKA OBLIKA raztopina za injiciranje Brezbarvna, bistra raztopina.
Musculoskeletal and connective tissue disorders Very common: Pain in limb 
Zelo pogosto: bolečina v okončinah Pogosto: mišični krči
Glucocorticoid-induced osteoporosis 
Osteoporoza povzročena z glukokortikoidi
Troubleshooting 
Nosečnost
• abnormal heart sound 
• nenormalno bitje srca
The most commonly reported adverse reactions in patients treated with FORSTEO are nausea, pain in limb, headache and dizziness. 
V kliničnih preskušanjih so z ≥ 1 % razliko v pogostnosti od placeba poročali o naslednjih reakcijah: vrtoglavica, slabost, bolečina v okončinah, omotica, depresija, dispneja.
Name and address of the manufacturer of the biological active substance 
PRILOGA II A. IZDELOVALEC BIOLOŠKE UČINKOVINE IN
• increased need to pass water 
• naključno uhajanje seča • povečana potreba po mokrenju
When you have finished, the black injection button should be all the way in. 7) If you still see the yellow shaft showing, please contact your doctor or pharmacist 8) Put the large needle cover on needle. 
7) Če še vedno vidite rumeni valj, se prosimo obrnite na vašega zdravnika ali farmacevta.
Cleaning Your FORSTEO 
Deli injekcijskega peresnika Forsteo*
• Keep the FORSTEO out of the sight and reach of children. 
• Zdravilo FORSTEO shranjujte nedosegljivo otrokom!
Tél/Tel: + 32 (0) 2 548 84 84 
Luxembourg/Luxemburg Eli Lilly Benelux S.A. /N.V Tél/Tel: + 32-(0)2 548 84 84
This leaflet was last revised in 
V splošnem so protitelesa prvič zaznali po
NAME OF THE MEDICINAL PRODUCT FORSTEO 20 micrograms/80 microliters solution for injection in pre-filled pen Teriparatide 
FORSTEO 20 mikrogramov/80 mikrolitrov raztopina za injiciranje v napolnjenem injekcijskem peresniku
FORSTEO 20 micrograms (µg)/ 80 microlitres solution for injection, in pre-filled pen Instructions for use 
FORSTEO 20 mikrogramov/80 mikrolitrov raztopina za injiciranje v napolnjenem injekcijskem peresniku teriparatid
ask your doctor. 
Posvetujte se tudi,
België/Belgique/Belgien Eli Lilly Benelux S.A./N.V. 
België/Belgique/Belgien Eli Lilly Benelux S.A./N.V Tél/Tel: + 32-(0)2 548 84 84
(See section 6.6.) 
(Glejte poglavje 6.6.)
From a microbiological point of view, the product must be used immediately. 
Z mikrobiološkega stališča je zdravilo treba uporabiti takoj.
Therefore, this medicine should not be used in children. 
Tega zdravila se torej ne sme uporabljati pri otrocih.
Storage beyond 24 hours or freezing is not recommended. 
Shranjevanje prek 24 ur ali zamrzovanje nista priporočljiva.
• If you have ever had kidney disease. 
• Če ste kadarkoli imeli bolezen ledvic.
The dose you will need is calculated based on your body weight. 
Potreben odmerek se izračuna na podlagi vaše telesne mase.
Frequencies are defined as: very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100) or not known (cannot be estimated from the available data). 
Pogostnosti so opredeljene kot: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100) ali neznano (ni mogoče oceniti iz razpoložljivih podatkov).
• Tell your doctor if you have diabetes mellitus. 
• Povejte zdravniku, če imate diabetes mellitus (sladkorno bolezen).
In both studies, tumours were observed within 3 months of dosing. 
V obeh študijah so tumorje opazili v 3 mesecih uporabe.
Using Vistide with food and drink 
Uporaba zdravila Vistide skupaj s hrano in pijačo
This medicinal product must not be mixed with other medicinal products or diluents except those mentioned in section 6.6. 
Zdravila ne smemo mešati z drugimi zdravili ali topili razen s tistimi, ki so omenjena v poglavju 6.6.
The use of an anti-emetic may be necessary. 
Potrebna utegne biti uporaba antiemetika.
The efficacy and safety of cidofovir in such conditions has not been established. 
Učinkovitost in varnost cidofovira pod takšnimi pogoji nista ugotovljeni.
Patient monitoring 
Opazovanje bolnikov
It is very important to tell your doctor if you are receiving other medicines that may damage your kidneys. 
Zelo pomembno je, da zdravnika obvestite, ali jemljete druga zdravila, ki lahko okvarijo vaše ledvice.
Antiviral activity is seen at concentrations significantly below those which cause cell death. 
Protivirusno delovanje je opazno v koncentracijah, bistveno manjših od tistih, ki povzročijo celično smrt.
Partially used vials should be discarded. 
Delno porabljene viale je treba zavreči.
Probenecid increases the AUC of zidovudine. 
Probenecid zveča AUC zidovudina.
Haemolytic anaemia has also occurred, and may be associated with G6DP deficiency. 
Pojavila se je tudi hemolitična anemija, ki je lahko povezana s pomanjkanjem G6DP.
• CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND Not applicable. 
• POGOJI ALI OMEJITVE V ZVEZI Z VARNO IN UČINKOVITO UPORABO Navedba smiselno ni potrebna.
Women of childbearing potential/Contraception in males and females: 
Ženske v rodni dobi/Kontracepcija pri moških in ženskah:
Handling and disposal 
Ravnanje in odstranjevanje
Important information about some of the ingredients of Vistide 
Pomembne informacije o nekaterih sestavinah zdravila Vistide
Cidofovir has negligible influence on the ability to drive and use machines. 
Cidofovir ima zanemarljiv vpliv na sposobnost vožnje in upravljanja s stroji.
• Vistide is not used for the treatment of HIV infection. 
• Zdravilo Vistide se ne uporablja za zdravljenje okužbe z virusom HIV.
Gilead Sciences Limited IDA Business & Technology Park Carrigtohill Co. Cork Ireland 
Gilead Sciences Limited IDA Business & Technology Park Carrigtohill Co. Cork Irska
Vistide has been shown to cause damage in unborn animals and should not be used during pregnancy unless the potential benefits justify the risks to the foetus. 
Dokazano je, da zdravilo Vistide povzroča okvare pri nerojenih živalih, in se ga med nosečnostjo ne sme uporabljati, razen če možne koristi upravičujejo tveganja za plod.
Appropriate precautions should continue to be employed to prevent transmission of HIV. 
Nadaljevati je treba z ustreznimi previdnostnimi ukrepi, da bi preprečili prenos HIV na druge.
If you have kidney problems, Vistide may not be appropriate treatment for you. 
Če imate težave z ledvicami, zdravilo Vistide za vas morda ni primeren način zdravljenja.
The fraction of the dose extracted during haemodialysis is 51.9 ± 11.0%. 
Med hemodializo ekstrahirani delež odmerka znaša 51,9 ± 11,0%.
Both patients were hospitalised and received prophylactic oral probenecid and vigorous hydration for 3 to 7 days. 
Oba bolnika sta bila hospitalizirana in sta dobila profilaktični peroralni probenecid in intenzivno hidracijo 3 do 7 dni.
The signs of nephrotoxicity were partially reversible in some patients. 
Znaki nefrotoksičnosti so bili pri nekaterih bolnikih delno reverzibilni.
You must take 3 doses of probenecid tablets orally on the same day as Vistide as shown in the following table: 
Vzeti morate 3 odmerke tablet probenecida peroralno na isti dan kot zdravilo Vistide, kot prikazuje naslednja tabela:
Dose in adults 
Odmerek pri odraslih
What is CMV retinitis? 
Kaj je citomegalovirusni retinitis?
Because many medicines are passed through to human milk, nursing mothers should stop Vistide or stop breast-feeding if they continue to receive 
Ker se v materino mleko izločajo številna zdravila, morajo doječe matere nehati dobivati zdravilo Vistide, ali pa morajo nehati dojiti, če še naprej dobivajo
The formulation is adjusted to pH 7.4. 
pH pripravka je uravnan na 7,4.
One patient received a single dose of 16.4 mg/kg and the other patient received a single dose of 17.3 mg/kg. 
En bolnik je dobil en sam odmerek 16,4 mg/kg, drugi bolnik pa en sam odmerek 17,3 mg/kg.
• If you are allergic (hypersensitive) to cidofovir or any of the other ingredients of Vistide. 
• Če ste alergični (preobčutljivi) na cidofovir ali katerokoli sestavino zdravila Vistide.
These side effects usually disappear when treatment with Vistide is stopped. 
Ti neželeni učinki ponavadi izginejo, ko se zdravljenje z zdravilom Vistide konča.
• CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE IMPOSED ON Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2). 
• POGOJI ALI OMEJITVE GLEDE OSKRBE IN UPORABE, PREDPISANI IMETNIKU Izdaja zdravila je le pod omejenimi pogoji in na recept (glejte Dodatek I: Povzetek glavnih značilnosti zdravila, poglavje 4.2).
In study GS-93-107 conducted in patients who had relapsed after treatment with other agents, the median time to retinitis progression was 115 days. 
V študiji GS-93-107, opravljeni pri bolnikih z relapsom po zdravljenju z drugimi zdravili, je bil mediani čas do napredovanja retinitisa 115 dni.
Vistide may cause short-term side effects such as fatigue or weakness. 
Zdravilo Vistide lahko povzroči kratkotrajne neželene učinke, npr. utrujenost in šibkost.
Vistide should be infused only into veins with adequate blood flow to permit rapid dilution and distribution. 
Infundirati se ga sme samo v vene, v katerih je pretok krvi dovolj velik, da omogoča hitro raztopitev in porazdelitev.
Detailed information on this product is available on the website of the European Medicines Agency http://www.ema.europa.eu/. 
Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila http://www.ema.europa.eu/.
For storage conditions of the diluted medicinal product, see section 6.3. 
Za pogoje shranjevanja raztopljenega zdravila glejte poglavje 6.3.
Each pack contains one 5 ml vial. 
Eno pakiranje vsebuje eno 5 ml vialo.
Other Cidofovir should be considered a potential carcinogen in humans (see section 5.3). 
Drugo Cidofovir je treba obravnavati kot potencialen kancerogen za človeka (glejte poglavje 5.3).
These medicines must be stopped at least 7 days before taking Vistide. 
Zdravljenje s temi zdravili je treba opustiti vsaj 7 dni pred začetkom zdravljenja z zdravilom Vistide.
One of these patients experienced a minor transient change in renal function, while the other patient had no change in renal function (see section 4.4). 
Pri enem od teh bolnikov je prišlo do majhne prehodne spremembe v delovanju ledvic, pri drugem pa se delovanje ledvic ni spremenilo (glejte poglavje 4.4).
Other types of IV set tubing and infusion bags have not been studied. 
Druge vrste intravenskih cevnih kompletov in infuzijskih vrečk niso raziskane.
• Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription, as these may interact with 
• Obvestite svojega zdravnika ali farmacevta, če jemljete ali ste pred kratkim jemali katerokoli zdravilo, tudi če ste ga dobili brez recepta, saj lahko pride do medsebojnega delovanja z zdravilom Vistide ali probenecidom.
These include: • tenofovir containing medicines, used to treat HIV-1 infection and/or chronic hepatitis B 
Ta vključujejo: • zdravila, ki vsebujejo tenofovir, ki se uporabljajo za zdravljenje okužb z virusom HIV-1 in/ali
Vistide must be administered by a healthcare professional (doctor or nurse) in a hospital setting. 
Zdravilo Vistide vam mora dati zdravstveni delavec (zdravnik ali medicinska sestra) v bolnišnici.
Starting (induction) treatment 
Začetno (uvajalno) zdravljenje
Like all medicines, Vistide can cause side effects, although not everybody gets them. 
Kot vsa zdravila ima lahko tudi zdravilo Vistide neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
Do not use Vistide 
Ne uporabljajte zdravila Vistide
Suspension of maintenance treatment with cidofovir should be considered in accordance with local recommendations for the management of HIV infected patients. 
Prenehanje vzdrževalnega zdravljenja s cidofovirom mora biti usklajeno z lokalnimi priporočili za vodenje bolnikov, okuženih s HIV.
Probenecid is not supplied with Vistide and should be obtained via the Marketing Authorisation Holder of probenecid. 
Probenecid ni dobavljen skupaj z zdravilom Vistide in ga je treba dobiti od imetnika dovoljenja za promet s probenecidom.
Reductions in blood cell and platelet counts have also occurred. 
Prišlo je tudi do znižanja števila vseh krvnih celic ter krvnih ploščic.
At the end of this leaflet, there is further information for healthcare professionals on how to administer Vistide. 
Ob koncu teh navodil so dodatne informacije za zdravstvene delavce za dajanje zdravila Vistide.
• Probenecid may interact with other medicines commonly used in the treatment of AIDS and AIDS-related illnesses, such as zidovudine (AZT). 
• Probenecid ima lahko medsebojne učinke z drugimi zdravili, ki se pogosto uporabljajo za zdravljenje AIDS-a in z AIDS-om povezanih bolezni, npr. z zidovudinom (AZT).
The safety and efficacy of Vistide have not been established in patients with hepatic disease and therefore it should be used with caution in this patient population. 
Varnost in učinkovitost zdravila Vistide pri bolnikih z boleznijo jeter nista bili dokazani, zato ga je treba pri tej populaciji bolnikov uporabljati previdno.
If visible particles or discolouration are observed, the vial should not be used. 
Če so opazni vidni delci ali obarvanje, se takšne viale ne sme uporabiti.
Use of cidofovir without concomitant probenecid has not been clinically investigated. 
Uporaba cidofovira brez sočasne uporabe probenecida klinično ni raziskana.
If you can tolerate the additional fluid load, your doctor may administer a second litre of fluid. 
Če prenesete dodatno obremenitev s tekočino, vam zdravnik lahko da še drugi liter tekočine.
The safety and efficacy of Vistide in children below 18 years of age have not been established. 
Varnost in učinkovitost zdravila Vistide pri otrocih, mlajših od 18 let nista bili dokazani.
• aminoglycosides, pentamidine or vancomycin (for bacterial infections) 
• aminoglikozide, pentamidin ali vankomicin (za bakterijske okužbe)
It must not be administered by other methods including intraocular injection (direct injection into the eye) or topically (on the skin). 
Ne sme se ga dati na drugačen način, vključno z intraokularnim injiciranjem (injicirati neposredno v oko) ali zunanje (na kožo).
Probenecid is only taken on the same day that Vistide is given. 
Probenecid se vzame samo na isti dan, kot se da zdravilo Vistide.
MARKETING AUTHORISATION NUMBER(S) EU/1/97/037/001 
ŠTEVILKA (ŠTEVILKE) DOVOLJENJA (DOVOLJENJ) ZA PROMET EU/1/97/037/001
The formulation is pH-adjusted with sodium hydroxide (and hydrochloric acid if needed) and contains no preservatives. 
Pripravek ima pH uravnan z natrijevim hidroksidom (in klorovodikovo kislino, če je potrebno) in ne vsebuje konzervansov.
Do not use Vistide after the expiry date which is stated on the label. 
Zdravila Vistide ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na ovojnini.
Direct intraocular injection of Vistide is contraindicated; direct injection may be associated with significant decreases in intraocular pressure and impairment of vision. 
Neposredno intraokularno injiciranje zdravila Vistide je kontraindicirano; neposredno injiciranje lahko spremljata pomembno znižanje očesnega tlaka in okvara vida.
• If you cannot take the medicine probenecid because of a serious allergy to probenecid or other sulfa-containing medicines (e.g. sulfamethoxazole). 
• Če ne morete jemati zdravila probenecid, ker imate resno alergijo na probenecid ali druga zdravila, ki vsebujejo žveplo (npr. sulfametoksazol).